130 related articles for article (PubMed ID: 9187102)
1. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay.
Ohyashiki K; Ohyashiki JH; Nishimaki J; Toyama K; Ebihara Y; Kato H; Wright WE; Shay JW
Cancer Res; 1997 Jun; 57(11):2100-3. PubMed ID: 9187102
[TBL] [Abstract][Full Text] [Related]
2. [Development of in situ TRAP assay detecting telomerase activity in cell].
Ohyashiki K; Yahata N; Ohyashiki JH
Nihon Rinsho; 1998 May; 56(5):1159-64. PubMed ID: 9613114
[TBL] [Abstract][Full Text] [Related]
3. [Detection of telomerase activity and its clinical application].
Ohyashiki K; Ohyashiki JH; Yahata N; Toyama K
Rinsho Byori; 1997 Dec; 45(12):1133-41. PubMed ID: 9437893
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization.
Heine B; Hummel M; Demel G; Stein H
J Pathol; 1998 Jun; 185(2):139-44. PubMed ID: 9713339
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in patients with chronic myeloid leukemia and lymphoma.
Bitisik O; Yavuz S; Yasasever V; Dalay N
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):3-12. PubMed ID: 11334367
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
7. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers.
Harada K; Yasoshima M; Ozaki S; Sanzen T; Nakanuma Y
J Pathol; 2001 Feb; 193(2):210-7. PubMed ID: 11180168
[TBL] [Abstract][Full Text] [Related]
8. [Detection of human telomerase activity by telomerase TRAP-ELISA assay].
Wei L; Guo Y; Yan Z
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):264-6. PubMed ID: 10920979
[TBL] [Abstract][Full Text] [Related]
9. Nonradioactive detection of telomerase activity using a PCR-ELISA-based telomeric repeat amplification protocol.
Emrich T; Karl G
Methods Mol Biol; 2002; 191():147-58. PubMed ID: 11951603
[No Abstract] [Full Text] [Related]
10. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
[TBL] [Abstract][Full Text] [Related]
11. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
[TBL] [Abstract][Full Text] [Related]
12. Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples.
Faraoni I; Graziani G; Turriziani M; Masci G; Mezzetti M; Testori A; Veronesi U; Bonmassar E
Lab Invest; 1999 Aug; 79(8):993-1005. PubMed ID: 10462037
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
14. Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe.
Wada Y; Yagihashi A; Kameshima H; Matsuura A; Sato N; Kikuchi K; Yajima T; Sasaki K; Uehara N; Watanabe N; Hirata K
Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):451-7. PubMed ID: 9436045
[TBL] [Abstract][Full Text] [Related]
15. Detection of telomerase activity by the TRAP assay and its variants and alternatives.
Fajkus J
Clin Chim Acta; 2006 Sep; 371(1-2):25-31. PubMed ID: 16616059
[TBL] [Abstract][Full Text] [Related]
16. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
[TBL] [Abstract][Full Text] [Related]
18. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol.
Herbert BS; Hochreiter AE; Wright WE; Shay JW
Nat Protoc; 2006; 1(3):1583-90. PubMed ID: 17406450
[TBL] [Abstract][Full Text] [Related]
19. [Expression of telomerase and its RNA in nasopharyngeal carcinoma].
Wen Z; Xiao J; Tang F; Tian Y; Zhao S; Chen B
Chin Med J (Engl); 2000 Jun; 113(6):525-8. PubMed ID: 11775871
[TBL] [Abstract][Full Text] [Related]
20. Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Bednarek AK; Sahin A; Brenner AJ; Johnston DA; Aldaz CM
Clin Cancer Res; 1997 Jan; 3(1):11-6. PubMed ID: 9815531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
